HLB bioStep Co.,Ltd. (KOSDAQ:278650)
South Korea · Delayed Price · Currency is KRW 3,150.00
+35.00 (1.12%)
At close: Jun 5, 2026
HLB bioStep Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -19,277 | -18,962 | -8,564 | -164.04 | -1,008 | 11,031 |
Depreciation & Amortization | 4,774 | 4,731 | 4,703 | 3,476 | 4,103 | 3,026 |
Loss (Gain) From Sale of Assets | -13.38 | -16.35 | -135.08 | 9.47 | -209.11 | 33.11 |
Asset Writedown & Restructuring Costs | 4,948 | 4,948 | - | - | 907.98 | - |
Loss (Gain) From Sale of Investments | -1,639 | -1,714 | -182.73 | -3,418 | -534.22 | 440.55 |
Loss (Gain) on Equity Investments | 4,536 | 4,460 | -1.68 | 488.74 | 1,891 | -3,608 |
Stock-Based Compensation | 1,438 | 1,541 | 1,445 | 442.17 | 444.01 | - |
Provision & Write-off of Bad Debts | 522.93 | 258.11 | 1,002 | -156.68 | 712.06 | -409.25 |
Other Operating Activities | 3,820 | 3,859 | -2,070 | 2,175 | 4,863 | 2,000 |
Change in Accounts Receivable | -1,582 | -1,003 | -5,035 | 1,441 | -1,277 | -1,362 |
Change in Inventory | -297.59 | -334.28 | 47.63 | 812.47 | -1,842 | -660.56 |
Change in Accounts Payable | 4,010 | 1,623 | 1,299 | -476.32 | 1,815 | 644.96 |
Change in Other Net Operating Assets | -3,600 | 3,697 | -4,178 | 561.78 | -3,386 | -2,673 |
Operating Cash Flow | -2,360 | 3,086 | -11,670 | 5,192 | 6,481 | 8,463 |
Operating Cash Flow Growth | - | - | - | -19.89% | -23.42% | -26.18% |
Capital Expenditures | -1,939 | -1,973 | -8,924 | -4,002 | -4,894 | -19,598 |
Sale of Property, Plant & Equipment | 66.9 | 347.06 | 6,971 | 38.18 | 148.13 | 6.36 |
Cash Acquisitions | - | - | -2,730 | - | -9,707 | -107.5 |
Divestitures | - | - | - | - | 8,494 | - |
Sale (Purchase) of Intangibles | -99.77 | -86.53 | -3 | -3.54 | -1,165 | -108.85 |
Investment in Securities | -4,343 | -3,902 | 5,943 | 57,393 | -78,115 | 503.72 |
Other Investing Activities | -130.54 | -158.5 | -61.05 | 3,236 | 3,650 | -163.07 |
Investing Cash Flow | -6,178 | -5,502 | 1,467 | 55,718 | -80,843 | -19,568 |
Short-Term Debt Issued | - | - | 2,900 | - | 3,400 | 2,462 |
Long-Term Debt Issued | - | 21,874 | 100 | - | 81,100 | 8,000 |
Total Debt Issued | 1,874 | 21,874 | 3,000 | - | 84,500 | 10,462 |
Short-Term Debt Repaid | - | -300 | -718.9 | - | -1,000 | -1,483 |
Long-Term Debt Repaid | - | -24,319 | -11,567 | -5,661 | -4,072 | -966.47 |
Total Debt Repaid | -1,269 | -24,619 | -12,286 | -5,661 | -5,072 | -2,449 |
Net Debt Issued (Repaid) | 604.57 | -2,745 | -9,286 | -5,661 | 79,428 | 8,013 |
Issuance of Common Stock | - | 155.36 | 2,794 | 183.18 | 942.75 | 2,249 |
Repurchase of Common Stock | -0.53 | - | -5,910 | -1,422 | - | - |
Dividends Paid | - | - | - | - | -1,530 | -1,132 |
Other Financing Activities | 1.02 | 1.24 | -25.11 | -85 | 4,224 | 83.5 |
Financing Cash Flow | 605.06 | -2,589 | -12,427 | -6,985 | 83,064 | 9,212 |
Foreign Exchange Rate Adjustments | -14.27 | -12.43 | 4.17 | 1.36 | 14.01 | 9.91 |
Miscellaneous Cash Flow Adjustments | -0 | - | - | - | - | - |
Net Cash Flow | -7,947 | -5,017 | -22,625 | 53,926 | 8,716 | -1,882 |
Free Cash Flow | -4,299 | 1,113 | -20,594 | 1,189 | 1,587 | -11,135 |
Free Cash Flow Growth | - | - | - | -25.03% | - | - |
Free Cash Flow Margin | -5.81% | 1.50% | -35.40% | 2.25% | 1.84% | -17.29% |
Free Cash Flow Per Share | -242.07 | 65.84 | -1226.35 | 77.53 | 113.33 | -795.47 |
Cash Interest Paid | 484.8 | 572.16 | 498.23 | 366.61 | 401.2 | 132.69 |
Cash Income Tax Paid | - | -72.94 | -107.2 | 763.61 | 2,287 | 891.74 |
Levered Free Cash Flow | -4,310 | 1,907 | -11,123 | -586.77 | 1,307 | -16,022 |
Unlevered Free Cash Flow | -2,820 | 3,189 | -10,587 | 1,583 | 3,961 | -15,907 |
Change in Working Capital | -1,470 | 3,982 | -7,866 | 2,339 | -4,689 | -4,051 |